RU2016149416A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016149416A3 RU2016149416A3 RU2016149416A RU2016149416A RU2016149416A3 RU 2016149416 A3 RU2016149416 A3 RU 2016149416A3 RU 2016149416 A RU2016149416 A RU 2016149416A RU 2016149416 A RU2016149416 A RU 2016149416A RU 2016149416 A3 RU2016149416 A3 RU 2016149416A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462009145P | 2014-06-06 | 2014-06-06 | |
| US62/009,145 | 2014-06-06 | ||
| US201462019289P | 2014-06-30 | 2014-06-30 | |
| US62/019,289 | 2014-06-30 | ||
| PCT/US2015/034372 WO2015188046A1 (en) | 2014-06-06 | 2015-06-05 | Omega-3 compositions, dosage forms, and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016149416A RU2016149416A (ru) | 2018-07-10 |
| RU2016149416A3 true RU2016149416A3 (enExample) | 2018-12-05 |
| RU2741965C2 RU2741965C2 (ru) | 2021-02-01 |
Family
ID=54767418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016149416A RU2741965C2 (ru) | 2014-06-06 | 2015-06-05 | Композиции c омега-3, лекарственные формы и способы их применения |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US9675575B2 (enExample) |
| EP (2) | EP3906920A1 (enExample) |
| JP (2) | JP6755186B2 (enExample) |
| KR (1) | KR102400958B1 (enExample) |
| CN (1) | CN106687113B (enExample) |
| AU (1) | AU2015269307C1 (enExample) |
| BR (1) | BR112016028561A8 (enExample) |
| CA (1) | CA2950344C (enExample) |
| CL (1) | CL2016003131A1 (enExample) |
| MX (1) | MX2016015791A (enExample) |
| MY (1) | MY186566A (enExample) |
| RU (1) | RU2741965C2 (enExample) |
| TW (1) | TWI725937B (enExample) |
| WO (1) | WO2015188046A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10709680B2 (en) * | 2011-07-18 | 2020-07-14 | Physicians Recommended Nutriceuticals, Llc | Methods for treating dry eye |
| CN106687113B (zh) * | 2014-06-06 | 2021-09-03 | 海洋原料公司 | ω-3组合物、剂型及使用方法 |
| CN110958731A (zh) | 2018-09-21 | 2020-04-03 | 鸿盛国际有限公司 | 发光二极管并联电路 |
| FR3103355B1 (fr) | 2019-11-26 | 2024-05-31 | Polaris | Composition d’huile de micro-organismes enrichie en acides gras polyinsaturés |
| FR3151183A1 (fr) | 2023-07-20 | 2025-01-24 | Microphyt | Nouvelle utilisation d’un extrait de la microalgue Phaeodactylum tricornutum |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8819110D0 (en) | 1988-08-11 | 1988-09-14 | Norsk Hydro As | Antihypertensive drug & method for production |
| FR2731015B1 (fr) | 1995-02-24 | 1997-05-30 | Sci Sartone | Procede d'enrichissement enzymatique d'huiles d'origine marine et les triglycerides d'acides gras polyinsatures ainsi obtenus |
| JP2000501131A (ja) * | 1995-11-24 | 2000-02-02 | ロダース・クロックラーン・ビー・ブイ | 魚油をベースとする組成物 |
| US7799365B2 (en) * | 2001-04-06 | 2010-09-21 | Burnbrae Farms Limited | Liquid egg composition including fish oil with omega-3 fatty acid |
| US7169385B2 (en) | 2003-09-29 | 2007-01-30 | Ronald G. Udell | Solubilized CoQ-10 and carnitine |
| SE0303513D0 (sv) | 2003-12-19 | 2003-12-19 | Pronova Biocare As | Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
| US20070020340A1 (en) * | 2005-07-25 | 2007-01-25 | David Rubin | Fish oil products for reducing cholesterol, low density lipoprotein, and hypertension |
| US20090182050A1 (en) | 2005-10-07 | 2009-07-16 | Ocean Nutrition Canada, Ltd. | Salts of Fatty Acids and Methods of Making and Using thereof |
| CA2634139C (en) | 2005-12-20 | 2015-06-23 | Cenestra, Llc. | Omega 3 fatty acid formulations |
| US9265745B2 (en) | 2005-12-21 | 2016-02-23 | Brudy Technology S.L. | Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage |
| CA2655769A1 (en) | 2006-06-23 | 2007-12-27 | The Procter & Gamble Company | Concentrated omega-3 fatty acids and mixtures containing them |
| WO2008036353A2 (en) | 2006-09-19 | 2008-03-27 | The Trustees Of Columbia University In The City Of New York | Omega-3 diglyceride emulsions |
| EP2147088A4 (en) * | 2007-04-26 | 2010-05-05 | Patrick Adlercreutz | FERTILIZED MILK OILS COMPRISING MULTIPLE-UNSATURATED FATTY ACIDS, COMPRISING EICOSAPENTAIC ACID (EPA) AND DOCOSAHEXAIC ACID (DHA), AND MANUFACTURING METHOD THEREFOR |
| US20100119600A1 (en) | 2007-06-01 | 2010-05-13 | Joar Opheim | Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof |
| CL2008002020A1 (es) | 2007-07-12 | 2008-11-14 | Ocean Nutrition Canada Ltd | Metodo de modificacion de un aceite, que comprende hidrolizar gliceridos con una solucion de lipasa thermomyces lanuginosus, separar la fraccion de acido graso saturado de la fraccion de glicerido hidrolizado y esterificar los gliceridos hidrolizados en la presencia de candida antarctica lipasa b; y composicion de aceite. |
| WO2009017102A1 (ja) * | 2007-07-30 | 2009-02-05 | Nippon Suisan Kaisha, Ltd. | Epa濃縮油およびdha濃縮油の製造方法 |
| KR101045397B1 (ko) | 2008-07-04 | 2011-06-30 | 주식회사동우산업 | 오메가-3 지방산 함량이 높은 정제 오징어유의 제조방법 |
| GB0813599D0 (en) | 2008-07-24 | 2008-09-03 | Pharma Marine As | Method |
| RS53694B1 (sr) * | 2008-08-07 | 2015-04-30 | Spa Societa' Prodotti Antibiotici S.P.A. | Dugoročno lečenje simptomatske srčane insuficijencije |
| US20100236137A1 (en) * | 2008-09-23 | 2010-09-23 | LiveFuels, Inc. | Systems and methods for producing eicosapentaenoic acid and docosahexaenoic acid from algae |
| AU2010222648B2 (en) * | 2009-03-09 | 2016-07-07 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof |
| CN101695487B (zh) * | 2009-09-22 | 2012-01-18 | 北京百慧生化制药有限责任公司 | 一种高纯度epa-e、dha-e的多烯酸乙酯乳剂 |
| FR2955459B1 (fr) | 2010-01-28 | 2013-11-22 | Polaris | Composition huileuse riche en monoglycerides de dha |
| US20110223246A1 (en) * | 2010-03-10 | 2011-09-15 | Joar Opheim | Docosahexaenoic acid bound in phospholipids and method of recovering same from a natural source |
| WO2011133841A2 (en) | 2010-04-23 | 2011-10-27 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Intravenous omega-3 fatty acid compositions & method of use |
| KR101904392B1 (ko) * | 2010-09-24 | 2018-10-05 | 프로노바 바이오파마 너지 에이에스 | 오메가-3 지방산을 농축하기 위한 공정 |
| US20120252888A1 (en) * | 2011-03-29 | 2012-10-04 | Palupa Medical Ltd. | Compositions and Methods for Treating Neurologic Disorders |
| AU2012347606A1 (en) * | 2011-12-08 | 2014-06-26 | Metaproteomics, Llc | Supplemented oil compositions and methods for improved health |
| WO2013093630A2 (en) * | 2011-12-22 | 2013-06-27 | Pronova Biopharma Norge As | Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof |
| CN110478342A (zh) | 2012-05-10 | 2019-11-22 | 索卢泰克斯Na有限责任公司 | 含有天然专门促消退介质及其前体的具有抗炎活性的油 |
| EP3756658A1 (en) | 2012-09-24 | 2020-12-30 | Aker Biomarine Antarctic As | Omega -3 compositions |
| US20130310457A1 (en) | 2013-07-25 | 2013-11-21 | Niral Ramesh | Solid-in-oil dispersions |
| CN106687113B (zh) * | 2014-06-06 | 2021-09-03 | 海洋原料公司 | ω-3组合物、剂型及使用方法 |
-
2015
- 2015-06-05 CN CN201580030195.7A patent/CN106687113B/zh active Active
- 2015-06-05 EP EP21157298.7A patent/EP3906920A1/en active Pending
- 2015-06-05 MX MX2016015791A patent/MX2016015791A/es unknown
- 2015-06-05 EP EP15803689.7A patent/EP3151826A4/en not_active Ceased
- 2015-06-05 CA CA2950344A patent/CA2950344C/en active Active
- 2015-06-05 RU RU2016149416A patent/RU2741965C2/ru active
- 2015-06-05 MY MYPI2016704514A patent/MY186566A/en unknown
- 2015-06-05 WO PCT/US2015/034372 patent/WO2015188046A1/en not_active Ceased
- 2015-06-05 JP JP2016569985A patent/JP6755186B2/ja active Active
- 2015-06-05 BR BR112016028561A patent/BR112016028561A8/pt not_active IP Right Cessation
- 2015-06-05 KR KR1020167034160A patent/KR102400958B1/ko active Active
- 2015-06-05 AU AU2015269307A patent/AU2015269307C1/en active Active
- 2015-06-05 TW TW104118318A patent/TWI725937B/zh active
-
2016
- 2016-05-04 US US15/146,680 patent/US9675575B2/en active Active
- 2016-12-05 CL CL2016003131A patent/CL2016003131A1/es unknown
-
2017
- 2017-05-19 US US15/600,124 patent/US10034849B2/en active Active
-
2018
- 2018-06-29 US US16/023,904 patent/US10172819B2/en active Active
-
2019
- 2019-01-04 US US16/240,534 patent/US11160777B2/en active Active
-
2020
- 2020-04-06 JP JP2020068334A patent/JP2020105224A/ja active Pending